Startups & growth Analysis
Minutia develops insulin-producing cell transplants clinicians could monitor
Minutia is developing insulin-producing cell transplants with nanosensors that could help clinicians monitor whether the implanted cells survive.
M
Minutia develops insulin-producing cell transplants and nanosensors intended to monitor graft health in people with diabetes.
Overview
Minutia develops insulin-producing cell transplants combined with nanosensors for people with diabetes. Its preclinical approach aims to give transplant teams information about the survival of implanted cells.
The company has reported mouse-study results and received research grant support for work on immune resilience.
- Legal name
- Minutia, Inc.
Loading profile details…
Industries
- Industry category
- Healthcare & Life Sciences
- Specific industry
- Biotech Research
Classification sources and history
Biotech Research · Business involvement
As of 2026-11-09
Loading recent changes…
Sources & editorial review
(4)
- Minutia homepage
- Minutia preclinical data release
- Minutia CIRM grant announcement
- CIRM immune-cloaking award
Editorial profile by MoneyMakers. Sources reviewed .
